Denis Chem Lab Limited

DENISCHEM6

INE051G01012

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-05-16 EDT			5-day change	1st Jan Change
185.3 ^INR	-1.59%		-8.83%	+46.19%

2023	Denis Chem Lab Limited Declares Dividend for the Financial Year Ended on 31 March 2023	CI
2023	Denis Chem Lab Limited Proposes Dividend for the Financial Year Ended 31 March, 2023, Payable on or After September 29, 2023	CI

Denis Chem Lab Limited Declares Dividend for the Financial Year Ended on 31 March, 2021

September 28, 2021 at 05:33 am

Denis Chem Lab Limited at its AGM to be held on 28 September, 2021, declared a dividend of INR 0.75/- per Equity Share, for the financial year ended on 31 March, 2021.

Latest news about Denis Chem Lab Limited

Denis Chem Lab Limited Declares Dividend for the Financial Year Ended on 31 March 2023	23-09-29	CI
Denis Chem Lab Limited Proposes Dividend for the Financial Year Ended 31 March, 2023, Payable on or After September 29, 2023	23-07-17	CI
Denis Chem Lab Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	23-05-30	CI
Denis Chem Lab Limited Approves Dividend for Year Ended 31 March 2022	22-09-28	CI
Denis Chem Lab Limited Proposes Final Dividend for the Financial Year Ended 31 March 2022, Payable on or After 28 September, 2022	22-07-19	CI
Denis Chem Lab Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022	22-05-26	CI
Denis Chem Lab Limited Declares Dividend for the Financial Year Ended on 31 March, 2021	21-09-28	CI
Denis Chem Lab Limited Proposes Final Dividend for the Financial Year Ended on 31 March 2021	21-08-15	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021	21-08-13	CI
Denis Chem Lab : Swings to Loss in Fiscal Q4; Shares Slump 10%	21-06-08	MT
Denis Chem Lab Limited Recommends Final Dividend for the Financial Year Ended March 31, 2021	21-06-07	CI
Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2021	21-06-07	CI
Denis Chem Lab Limited Announces Standalone Audited Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2020	20-06-26	CI
Denis Chem Lab Limited Announces Resignation of Nahoosh J. Jariwala as Independent Director	20-02-24	CI
Denis Chem Lab Limited Reports Unaudited Earnings Results for the Quarter and Nine Months Ended on 31 December, 2019	20-02-13	CI
Denis Chem Lab Limited Announces Resignation of Janak G. Nanavati as Independent Director	19-12-14	CI
Denis Chem Lab Limited Declares Final Dividend for the Year Ended 31 March, 2019	19-09-26	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019	19-08-13	CI
Denis Chem Lab Limited Proposes Final Dividend for the Year Ended 31 March, 2019, Payable on or After 28 September, 2019	19-07-18	CI
Denis Chem Lab Limited Recommends Dividend for the Year Ended March 31, 2019	19-05-25	CI
Denis Chem Lab Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2019	19-05-25	CI
Denis Chem Lab Limited Appoints Nahoosh Jayvadan Jariwala as an Independent Director	19-03-18	CI
Denis Chem Lab Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018	19-02-11	CI
Denis Chem Lab Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	18-11-05	CI
Denis Chem Lab Limited Announces Audited Earnings Results for the Year Ended March 31, 2018	18-08-17	CI

Denis Chem Lab Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing pharmaceutical transfusion solution in bottles. It offers a range of sterile intravenous injectables for human and veterinary consumption. Its product offerings include carbohydrate solutions, carbohydrate in sodium chloride solutions, sodium chloride solutions, potassium chloride solutions, sodium lactate/ Ringer's solution, multi electrolyte solutions, dialysis solutions, mannitol solutions, irrigation solutions, plasma volume expanders, amino acids, antibiotic solutions and other miscellaneous products. It manufactures sterile intravenous injectables in filled volumes ranging from 100 milliliters to 10 liters. In addition to manufacturing its own products, it sells under its own brands. The Company also uses its facility to manufacture products on a contract basis for third parties, including certain multinational pharmaceutical companies.

Sector

Pharmaceuticals

Calendar

2024-05-27 - Q4 2024 Earnings Release

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DENIS CHEM LAB LIMITED	+46.19%	31.32M
ELI LILLY AND COMPANY	+35.01%	709B
NOVO NORDISK A/S	+30.70%	595B
JOHNSON & JOHNSON	-2.60%	367B
MERCK & CO., INC.	+20.83%	334B
ABBVIE INC.	+5.69%	289B
ASTRAZENECA PLC	+14.34%	239B
NOVARTIS AG	+9.49%	211B
ROCHE HOLDING AG	-4.46%	203B
AMGEN INC.	+10.77%	171B

Other Pharmaceuticals